Atos reports first quarter 2024 performance
25/04/2024
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in ...
Read moreFourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, ...
Read moreFull exercise of the over-allotment optionfor €36 million Success of the transaction with afinal size of €278 million Paris, France, ...
Read morePHOENIX, April 16, 2024 (GLOBE NEWSWIRE) -- Mobivity Holdings Corp. (OTCQB: MFON), a provider of technology connecting mobile gaming audiences ...
Read moreNEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Ezra, the healthcare AI startup transforming early cancer detection through full body ...
Read moreIRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for ...
Read moreIn a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a ...
Read moreSuccessful completion of business combination with Honeycomb Battery CompanyShares commenced trading on Nasdaq Global on February 2, 2024 DALLAS, April ...
Read moreNUREMBERG, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Embedded World -- Micron Technology, Inc. (Nasdaq: MU), today announced that it has ...
Read moreNEW YORK and TOKYO, April 08, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.